This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haddad, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haddad, P. M.
The British Journal of Psychiatry (2004) 184: s80-S86
© 2004 The Royal College of Psychiatrists

Antipsychotics and diabetes: review of non-prospective data

Peter M. Haddad, MD MRCPsych

Cromwell House, Bolton, Salford and Trafford Mental Health NHS Trust, Cromwell Road, Eccles, Salford M30 0GT, UK

Declaration of interest P.M.H. has received lecture fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co. and Janssen-Cilag

Background Much of the existing data regarding the relationship between antipsychotic medications and diabetes mellitus are non-prospective.

Aims To review critically non-prospective studies examining antipsychotic medications as risk factors for diabetes mellitus.

Method Database and manual searches.

Results Anecdotal reports indicate that conventional and atypical antipsychotics can cause diabetes mellitus. However, retrospective studies cannot reliably quantify this association, as they do not adequately control for confounding risk factors for diabetes, or for variation in detection and diagnosis of this illness. Most studies report a higher rate of diabetes in patients who use antipsychotic medication than in non-users, and in patients taking atypical v. conventional antipsychotics. Studies assessing the relative risks of diabetes between individual atypical antipsychotics are contradictory.

Conclusions Retrospective data are of limited value. Well-designed prospective studies, which account for potential confounders, are needed to investigate the true association between antipsychotic medications and diabetes.




This article has been cited by other articles:


Home page
 Psychiatr. Bull.Home page
C. J. Tarrant
Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care
Psychiatr. Bull., August 1, 2006; 30(8): 286 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
D. P. J. OSBORN, I. NAZARETH, and M. B. KING
Risk for coronary heart disease in people with severe mental illness: Cross-sectional comparative study in primary care
The British Journal of Psychiatry, March 1, 2006; 188(3): 271 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
T. G. Dinan
Introduction
The British Journal of Psychiatry, April 1, 2004; 184(47): s53 - s54.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
R. I. G. Holt
Diagnosis, epidemiology and pathogenesis of diabetes mellitus: an update for psychiatrists
The British Journal of Psychiatry, April 1, 2004; 184(47): s55 - s63.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Antipsychotics and diabetes: review of non-prospective data is not systematic
Micheal D Sriescoldu
BJP Online, 17 Oct 2004 [Full text]